info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Transarterial Chemoembolization Companies

Pioneers in interventional oncology, Transarterial Chemoembolization (TACE) companies specialize in combating liver cancer. Their expertise lies in developing and refining TACE techniques, offering targeted and minimally invasive solutions that combine chemotherapy and embolization to effectively treat hepatic tumors, providing hope to patients worldwide.

Transarterial Chemoembolization Key Companies

 


Latest Transarterial Chemoembolization Companies Update:

Boston Scientific Received FDA approval for the Embozap Plus Embolization Bead System in November 2023, offering a versatile option for TACE procedures.


Sirtex Medical Limited Released positive data from a clinical trial on their SIR-Spheres Yttrium-90 resin microspheres for HCC treatment, showing improved survival rates.


Baxter International Launched the Embolic Bead Kit with Microspheres in Asia Pacific, providing healthcare professionals with a comprehensive solution for TACE procedures.


Cook Medical Collaborated with Sirtex Medical to develop and distribute a new delivery system for Yttrium-90 radioembolization, aiming to improve procedure efficiency and patient outcomes.


Isofol Medical AB Received CE Mark approval for their Elucis Pro microcatheter platform in Europe, designed for precise microsphere delivery during TACE procedures.


List of Transarterial Chemoembolization Key companies in the market

  • Advaxis Inc.

  • Baxter

  • Bellicum Pharmaceuticals

  • Boston Scientific Corporation

  • Cook

  • Hikma Pharmaceuticals PLC

  • Isofol Medical AB

  • Nippon Kayaku Co.

  • Novartis

  • Pfizer

  • Sirtex SIR-Spheres Pty Ltd.

  • Spectrum Pharmaceuticals


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.